SurvivorNet on MSN
Muscle-invasive bladder cancer: Durvalumab + Enfortumab Vedotin treatment combination granted priority review by FDA
The FDA is reviewing durvalumab with enfortumab vedotin for patients with muscle-invasive bladder cancer who cannot receive ...
Treatments for bladder cancer include surgery, chemotherapy, and radiation therapy. Newer treatment options include immunotherapy and targeted therapy. Doctors may administer medications directly into ...
A phase I/II study of intraperitoneal (IP) paclitaxel (PTX) in patients with metastatic appendiceal adenocarcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results